Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS) (N-Term) Peptide
Quick Overview for Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS) (N-Term) Peptide (ABIN5671998)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- MDSVEKGAAT SVSNPRGRPS RGRPPKLQRN SRGGQGRGVE KPPHLAALIL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- CMAS Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CMAS (Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS))
-
Background
-
This gene encodes an enzyme that converts N-acetylneuraminic acid (NeuNAc) to cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-NeuNAc). This process is important in the formation of sialylated glycoprotein and glycolipids. This modification plays a role in cell-cell communications and immune responses. Alternative splicing results in multiple transcript variants.
Alias Symbols: CSS
Protein Size: 434 -
Gene ID
- 55907
-
NCBI Accession
- NM_018686, NP_061156
-
UniProt
- Q8NFW8
Target
-